Literature DB >> 17525142

Heme oxygenase-1 exacerbates early brain injury after intracerebral haemorrhage.

Jian Wang1, Sylvain Doré.   

Abstract

Because heme oxygenase (HO) is the rate limiting enzyme in the degradation of the pro-oxidant hemin/heme from blood, here we investigated the contribution of the inducible HO-1 to early brain injury produced by intracerebral haemorrhage (ICH). We found that after induction of ICH, HO-1 proteins were highly detectable in the peri-ICH region predominantly in microglia/macrophages and endothelial cells. Remarkably, the injury volume was significantly smaller in HO-1 knockout (HO-1-/-) mice than in wild-type controls 24 and 72 h after ICH. Although the brain water content did not appear to be significantly different, the protection in HO-1-/- mice was associated with a marked reduction in ICH-induced leucocyte infiltration, microglia/macrophage activation and free radical levels. These data reveal a previously unrecognized role of HO-1 in early brain injury after ICH. Thus, modulation of HO-1 signalling should be assessed further in clinical settings, especially for haemorrhagic states.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17525142      PMCID: PMC2291147          DOI: 10.1093/brain/awm095

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  51 in total

1.  Experimental intracerebral hemorrhage in rats. Magnetic resonance imaging and histopathological correlates.

Authors:  M R Del Bigio; H J Yan; R Buist; J Peeling
Journal:  Stroke       Date:  1996-12       Impact factor: 7.914

2.  Hemoglobin potentiates central nervous system damage.

Authors:  S M Sadrzadeh; D K Anderson; S S Panter; P E Hallaway; J W Eaton
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

3.  Heme oxygenase 1 is required for mammalian iron reutilization.

Authors:  K D Poss; S Tonegawa
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

4.  Hemoglobin-mediated oxidant damage to the central nervous system requires endogenous ascorbate.

Authors:  S M Sadrzadeh; J W Eaton
Journal:  J Clin Invest       Date:  1988-11       Impact factor: 14.808

5.  Heme oxygenase-1 and heat shock protein 70 induction in glia and neurons throughout rat brain after experimental intracerebral hemorrhage.

Authors:  P G Matz; P R Weinstein; F R Sharp
Journal:  Neurosurgery       Date:  1997-01       Impact factor: 4.654

6.  Protective effects of free radical inhibitors in intracerebral hemorrhage in rat.

Authors:  J Peeling; H J Yan; S G Chen; M Campbell; M R Del Bigio
Journal:  Brain Res       Date:  1998-06-08       Impact factor: 3.252

7.  Enlargement of spontaneous intracerebral hemorrhage. Incidence and time course.

Authors:  S Kazui; H Naritomi; H Yamamoto; T Sawada; T Yamaguchi
Journal:  Stroke       Date:  1996-10       Impact factor: 7.914

8.  Acute leukocyte and temperature response in hypertensive intracerebral hemorrhage.

Authors:  S Suzuki; R E Kelley; B K Dandapani; Y Reyes-Iglesias; W D Dietrich; R C Duncan
Journal:  Stroke       Date:  1995-06       Impact factor: 7.914

9.  Endothelial-cell heme uptake from heme proteins: induction of sensitization and desensitization to oxidant damage.

Authors:  J Balla; H S Jacob; G Balla; K Nath; J W Eaton; G M Vercellotti
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-15       Impact factor: 11.205

10.  Citicoline treatment for experimental intracerebral hemorrhage in mice.

Authors:  W Clark; L Gunion-Rinker; N Lessov; K Hazel
Journal:  Stroke       Date:  1998-10       Impact factor: 7.914

View more
  163 in total

1.  Efficacy of the lipid-soluble iron chelator 2,2'-dipyridyl against hemorrhagic brain injury.

Authors:  He Wu; Tao Wu; Mingchang Li; Jian Wang
Journal:  Neurobiol Dis       Date:  2011-09-10       Impact factor: 5.996

2.  Iron accumulation and neurotoxicity in cortical cultures treated with holotransferrin.

Authors:  Jing Chen-Roetling; Wenpei Liu; Raymond F Regan
Journal:  Free Radic Biol Med       Date:  2011-08-30       Impact factor: 7.376

3.  Cerebroprotection of flavanol (-)-epicatechin after traumatic brain injury via Nrf2-dependent and -independent pathways.

Authors:  Tian Cheng; Wenzhu Wang; Qian Li; Xiaoning Han; Jing Xing; Cunfang Qi; Xi Lan; Jieru Wan; Alexa Potts; Fangxia Guan; Jian Wang
Journal:  Free Radic Biol Med       Date:  2015-12-25       Impact factor: 7.376

Review 4.  The role of the microglia in acute CNS injury.

Authors:  Masahito Kawabori; Midori A Yenari
Journal:  Metab Brain Dis       Date:  2014-03-29       Impact factor: 3.584

Review 5.  Heat shock proteins in the brain: role of Hsp70, Hsp 27, and HO-1 (Hsp32) and their therapeutic potential.

Authors:  Frank R Sharp; Xinhua Zhan; Da-Zhi Liu
Journal:  Transl Stroke Res       Date:  2013-08-03       Impact factor: 6.829

6.  Astrogliosis: a target for intervention in intracerebral hemorrhage?

Authors:  Sangeetha Sukumari-Ramesh; Cargill H Alleyne; Krishnan M Dhandapani
Journal:  Transl Stroke Res       Date:  2012-04-14       Impact factor: 6.829

7.  Chemokines and their receptors in intracerebral hemorrhage.

Authors:  Yao Yao; Stella E Tsirka
Journal:  Transl Stroke Res       Date:  2012-04-03       Impact factor: 6.829

8.  Bone marrow mononuclear cell transplantation promotes therapeutic angiogenesis via upregulation of the VEGF-VEGFR2 signaling pathway in a rat model of vascular dementia.

Authors:  Jianping Wang; Xiaojie Fu; Chao Jiang; Lie Yu; Menghan Wang; Wei Han; Liu Liu; Jian Wang
Journal:  Behav Brain Res       Date:  2014-02-28       Impact factor: 3.332

9.  Ginkgo biloba prevents transient global ischemia-induced delayed hippocampal neuronal death through antioxidant and anti-inflammatory mechanism.

Authors:  Jatin Tulsulkar; Zahoor A Shah
Journal:  Neurochem Int       Date:  2012-12-07       Impact factor: 3.921

10.  Up-regulation of heme oxygenase-1 in rat spleen after aniline exposure.

Authors:  Jianling Wang; Huaxian Ma; Paul J Boor; V M Sadagopa Ramanujam; G A S Ansari; M Firoze Khan
Journal:  Free Radic Biol Med       Date:  2009-12-04       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.